《中国医药科学》杂志欢迎您的投稿!.   今天是:        
刘锦洲,胡敏.百令胶囊对高通量血液透析患者残余肾功能保护的作用机制研究[J].中国医药科学,2024,14(7):82-85        基金项目:
百令胶囊对高通量血液透析患者残余肾功能保护的作用机制研究
Study on the mechanism of action of Bailing Capsules in protecting residual renal function in patients undergoing high-flux hemodialysis
  
DOI:
中文关键词:  百令胶囊;高通量血液透析;残余肾功能;炎性因子水平;营养相关状况
英文关键词:Bailing Capsules; High-flux hemodialysis; Residual renal function; Inflammatory factor levels; Nutrition-related status
作者单位
刘锦洲,胡敏 广东省江门市新会区人民医院肾内风湿科,广东江门 529100 
摘要点击次数: 198
全文下载次数: 194
中文摘要:
      [摘要] 目的 研究百令胶囊对高通量血液透析患者残余肾功能(RRF)保护作用的机制。 方法 将江门市新会区人民医院2022年1月至2023年5月60例进行高通量血液透析治疗的患者按随机数表法分为对照组(n=30,常规治疗)和研究组(n=30,常规治疗+百令胶囊治疗),分析并比较两组患者RRF相关指标、炎性因子水平、营养相关状况。 结果 治疗后,两组血肌酐(Scr)、尿素氮(BUN)及24 h尿蛋白定量水平均较治疗前降低,肌酐清除率(Ccr)水平较治疗前升高,且研究组的Scr、BUN及24 h尿蛋白定量水平均低于对照组,而Ccr水平高于对照组,差异有统计学意义(P < 0.05)。治疗后,两组血红蛋白(Hb)、白蛋白(ALB)、转铁蛋白(TRF)、前白蛋白(PA)水平均较治疗前升高,主观整体营养状况评估量表(SGA)总评分均较治疗前降低,且研究组的Hb、ALB、TRF、PA水平均高于对照组,SGA总评分低于对照组,差异有统计学意义(P < 0.05)。治疗后,两组超敏C-反应蛋白(hs-CRP)、降钙素原(PCT)水平均较治疗前降低,且研究组的hs-CRP、PCT水平低于对照组,差异有统计学意义(P < 0.05)。 结论 在对高通量血液透析患者进行治疗时,使用百令胶囊辅助常规治疗可明显改善RRF相关指标和营养相关状况,并有助于调节炎性因子水平。
英文摘要:
      [Abstract] Objective To investigate the mechanism of action of Bailing Capsules in protecting residual renal function (RRF) in patients undergoing high-flux hemodialysis. Methods A total of 60 patients who underwent high-flux hemodialysis treatment at Jiangmen Xinhui People’s Hospital from January 2022 to May 2023 were divided into a control group (receiving conventional treatment) and a study group (receiving conventional treatment + Bailing Capsules treatment) by a random number table, with 30 cases in each group. RRF related indicators, inflammatory factor levels, and nutrition-related status of the two groups of patients were analyzed and compared. Results After treatment, the quantitative levels of serum creatinine (Scr), blood urea nitrogen (BUN), and 24-hour urine protein in both groups decreased compared to those before treatment, while the level of endogenous creatinine clearance rate (Ccr) increased compared to that before treatment. The quantitative levels of Scr, BUN, and 24-hour urine protein in the study group were lower than those in the control group, while the Ccr levels were higher than those in the control group, with statistically significant differences (P < 0.05). After treatment, the levels of hemoglobin (Hb), albumin (ALB), transferrin (TRF), and prealbumin (PA) in both groups increased compared to those before treatment, and the total subjective global assessment (SGA) score decreased compared to that before treatment. Moreover, the levels of Hb, ALB, TRF, and PA in the study group were higher than those in the control group. The total score of the SGA was lower in the study group than in the control group, with statistically significant differences (P < 0.05). After treatment, the levels of hypersensitive C-reactive protein (hs-CRP) and procalcitonin (PCT) in both groups decreased compared to those before treatment, and the levels of hs-CRP and PCT in the study group were lower than those in the control group, with statistically significant differences (P < 0.05). Conclusion When treating patients undergoing high-flux hemodialysis, the use of Bailing Capsules as an adjunct to routine treatment can significantly improve RRF related indicators and nutrition-related status, and help regulate inflammatory factor levels.
查看全文  查看/发表评论  下载PDF阅读器
关闭
关键词: 中国医药科学 中国医学 中国医学科学 中华医学 医学杂志 临床医学杂志 医学期刊 中国预防医学 中华预防医学 预防医学杂志 中国药学 药学杂志
药理杂志 中国中医 中医杂志 中华中医药 中医药杂志 中国医疗 医疗器械杂志 中国中西医结合 中国医药 医药杂志 医药期刊 医药论文 医学论文 科研论文 职称论文
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=08EE5A5866ACE4409762E3AC9C74D7E29D116661650506817F2300662977023C432150D20B35C98C1B98D39D2992DDE0C44CF130761F690D272DC91AC76C674F79CFCE449EEA7B22F4EF55F5CBA386F24BC10F8F3B77A70590939359E44BAF25D397B63712BCD1D1A8CA701ACCB698F2ED0E5F5DA6C0692B2FAECDF68113D3F3448CDFDCA0B1A54E914AC51B9C0E0A18&pcid=&cid=&jid=&yid=B80136CCD8DCBAA1&aid=&vid=&iid=DF92D298D3FF1E6E&sid=0D0D661F0B316AD5&eid=CD775AE9DDBD7B53&fileno=20240306&flag=1&is_more=0">